Magnesium for Migraine Prevention
For migraine prevention, prescribe oral magnesium 600 mg daily (as trimagnesium dicitrate or magnesium oxide), taken continuously for at least 2-3 months before assessing efficacy. 1
Dosing and Formulation
- The recommended dose is 600 mg (24 mmol) of elemental magnesium daily, typically given as trimagnesium dicitrate, which has the strongest evidence from randomized controlled trials 2, 3
- Magnesium oxide is an acceptable alternative formulation when trimagnesium dicitrate is unavailable 1
- Continue treatment for a minimum of 2-3 months at therapeutic dosing before declaring treatment failure, as clinical benefits may not become apparent immediately 1
Evidence for Efficacy
- In a prospective, multicenter, double-blind, placebo-controlled trial of 81 patients, oral magnesium 600 mg daily reduced attack frequency by 41.6% compared to 15.8% with placebo (p < 0.05) 2
- The number of migraine days and symptomatic medication consumption also decreased significantly with magnesium supplementation 2
- The VA/DoD guidelines suggest oral magnesium for migraine prevention with a weak recommendation based on consistent evidence 1
Position in Treatment Algorithm
- The American College of Physicians recommends starting oral magnesium for patients with ≥2 migraine attacks per month producing disability lasting ≥3 days per month 1
- Magnesium ranks among other preventive options including topiramate, propranolol, and valproate, but sits below stronger recommendations for CGRP antagonists 1
- Magnesium offers unique advantages for use during pregnancy, in patients with cardiovascular disease, and provides a low-cost option with minimal side effects 1
Side Effects and Tolerability
- The most common adverse effects are diarrhea (18.6%) and gastric irritation (4.7%), which are generally mild and well-tolerated 2
- The side effect profile is considerably more favorable than many other migraine preventive medications 2, 3
Critical Clinical Pitfalls to Avoid
- Do not discontinue magnesium prematurely—allow the full 2-3 month trial period at therapeutic dosing before declaring treatment failure, as benefits may take time to manifest 1
- Do not use magnesium hydroxide liquid formulations (like Milk of Magnesia) for migraine prevention, as these are laxative preparations with different pharmacokinetics and are not the studied formulation 4
- For acute migraine treatment, IV magnesium sulfate 1 g may be effective, but only in patients with low serum ionized magnesium levels (<0.54 mmol/l); non-responders often have normal or elevated levels and should receive alternative acute treatments like triptans or NSAIDs 1, 5, 6